الولايات المتحدة · منصات وبيانات · Morningstar

Newleos Announces $15.5 Million NIH Grant and Receipt of FDA Fast Track Designation for NTX-2001 to Treat Substance Use Disorders | Morningstar

نشره Morningstar · الولايات المتحدة منذ 10 س

Newleos also announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to NTX-2001 for the treatment of AUD. The FDA’s Fast Track process…

اقرأ المقال كاملًا على Morningstar سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.morningstar.com)

يستحق القراءة أيضًا

MarketBeat

‘It’s good to be old’: I’ve been invited to a dozen free meals that turn into annuity sales pitches. Should I stop going?

The Motley Fool

ICF vs. HAUZ: ICF Beats on Returns, but HAUZ Dominates on Fees and Yield

Investing.com

Newleos Announces $15.5 Million NIH Grant and Receipt of FDA Fast Track Designation for NTX-2001 to Treat Substance Use Disorders | Morningstar

مشاركة

يستحق القراءة أيضًا

SpaceX Sent Verizon and T-Mobile Stocks Tumbling—Did Wall Street Overreact?

Tech borrowers are picking up the tab: debt premium hits a 23-year high

Texas governor race tightens in prediction markets, but Abbott remains favored

‘It’s good to be old’: I’ve been invited to a dozen free meals that turn into annuity sales pitches. Should I stop going?

ICF vs. HAUZ: ICF Beats on Returns, but HAUZ Dominates on Fees and Yield

Treasury yields edge up as Election Day meets JOLTS, refunding